Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

Stock Information for Forte Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Forte Biosciences Inc.

Forte Biosciences to Host R&D Day December 3, 2024
Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.